Rhumbline Advisers Foghorn Therapeutics Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

A detailed history of Rhumbline Advisers transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 36,384 shares of FHTX stock, worth $172,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,384
Previous 33,335 9.15%
Holding current value
$172,824
Previous $310,000 44.84%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
BUY
$4.61 - $9.35 $14,055 - $28,508
3,049 Added 9.15%
36,384 $171,000
Q3 2024

Nov 12, 2024
SELL
$4.8 - $9.99 $12,360 - $25,724
-2,575 Reduced 7.17%
33,335 $310,000
Q2 2024

Aug 01, 2024
BUY
$5.05 - $8.0 $46,313 - $73,368
9,171 Added 34.3%
35,910 $206,000
Q1 2024

May 09, 2024
BUY
$2.82 - $7.94 $2,193 - $6,177
778 Added 3.0%
26,739 $179,000
Q4 2023

Feb 08, 2024
SELL
$2.94 - $6.76 $1,367 - $3,143
-465 Reduced 1.76%
25,961 $167,000
Q3 2023

Nov 09, 2023
BUY
$5.0 - $9.87 $4,995 - $9,860
999 Added 3.93%
26,426 $132,000
Q2 2023

Aug 08, 2023
BUY
$5.37 - $8.84 $606 - $998
113 Added 0.45%
25,427 $179,000
Q1 2023

May 11, 2023
SELL
$4.66 - $8.99 $2,036 - $3,928
-437 Reduced 1.7%
25,314 $157,000
Q4 2022

Feb 14, 2023
BUY
$5.44 - $9.46 $5,293 - $9,204
973 Added 3.93%
25,751 $164,000
Q3 2022

Nov 10, 2022
BUY
$7.52 - $18.01 $12,791 - $30,635
1,701 Added 7.37%
24,778 $213,000
Q2 2022

Aug 11, 2022
BUY
$8.48 - $16.84 $3,400 - $6,752
401 Added 1.77%
23,077 $314,000
Q1 2022

May 12, 2022
BUY
$8.87 - $22.1 $28,588 - $71,228
3,223 Added 16.57%
22,676 $345,000
Q4 2021

Feb 10, 2022
BUY
$10.79 - $22.87 $10,563 - $22,389
979 Added 5.3%
19,453 $445,000
Q3 2021

Nov 12, 2021
BUY
$8.33 - $15.02 $23,448 - $42,281
2,815 Added 17.98%
18,474 $257,000
Q2 2021

Aug 05, 2021
BUY
$9.32 - $13.26 $145,941 - $207,638
15,659 New
15,659 $167,000

Others Institutions Holding FHTX

# of Institutions
88
Shares Held
35.4M
Call Options Held
8.7K
Put Options Held
2.4K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $198M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email